SCHEMBL8288452

SCHEMBL8288452

COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc(N)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.58
NR1I2 O75469 2/20 0.58
NR3C1 P04150 2/20 0.58
TBXA2R P21731 2/20 0.58
CCKBR P32239 2/20 0.58
PDE4D Q08499 2/20 0.58
SCN5A Q14524 2/20 0.58
ABCB1 P08183 1/20 0.58
AGTR1 P30556 1/20 0.58
PTGS2 P35354 1/20 0.58
SLC29A1 Q99808 1/20 0.58
CACNA1C Q13936 5/20 0.57
CACNA1F O60840 4/20 0.57
CACNA1D Q01668 4/20 0.57
CACNA1S Q13698 4/20 0.57
CYP1A2 P05177 6/20 0.55
CYP3A4 P08684 6/20 0.55
CYP2C9 P11712 6/20 0.55
CYP2C19 P33261 6/20 0.55
MEN1 O00255 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10540800 0.92 ADORA3 (0.60) ADORA3CACNA1CCACNA1FCACNA1DCACNA1S
SCHEMBL8286960 0.87 MEN1 (0.73) ADORA3NR1I2NR3C1TBXA2RPDE4D
SCHEMBL10712075 0.86 ADORA3 (0.57) ADORA3NR1I2NR3C1TBXA2RCCKBR
SCHEMBL11004140 0.85 CACNA1C (0.72) ADORA3NR1I2NR3C1TBXA2RCCKBR
SCHEMBL8288455 0.85 ADORA3 (0.74) ADORA3NR1I2NR3C1TBXA2RPDE4D
SCHEMBL9733144 0.84 CACNA1C (0.62) ADORA3NR1I2NR3C1TBXA2RCCKBR
SCHEMBL7160394 0.83 CACNA1C (0.77) ADORA3NR1I2NR3C1TBXA2RCCKBR
SCHEMBL19017149 0.83 ADORA3 (0.60) ADORA3CACNA1CCACNA1FCACNA1DCACNA1S
SCHEMBL7159699 0.82 ADORA3 (0.81) ADORA3NR1I2NR3C1TBXA2RCCKBR
SCHEMBL30357961 0.82 ADORA3 (0.81) ADORA3NR1I2NR3C1TBXA2RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005042486-A1 1,4-DIHYDROPYRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE MYOGEN, INC. (US) 2005-05-12 WO disclosed